SCHEMBL3605733

SCHEMBL3605733

Cc1ccc(-c2ccc3ccn(CC(=O)NC(C)CN4CCCC4)c3c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.48
▸ KDM4E B2RXH2 1/20 0.48
▸ POLB P06746 1/20 0.48
▸ HPGD P15428 1/20 0.48
▸ APOBEC3A P31941 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.48
▸ APOBEC3G Q9HC16 1/20 0.48
▸ KMT2A Q03164 2/20 0.46
▸ NTSR1 P30989 5/20 0.45
▸ GRIN2B Q13224 4/20 0.43
▸ HTR7 P34969 1/20 0.41
▸ NPC1 O15118 2/20 0.40
▸ CHRM2 P08172 1/20 0.40
▸ ADRA2B P18089 1/20 0.40
▸ DRD3 P35462 1/20 0.40
▸ SIGMAR1 Q99720 1/20 0.40
▸ HRH3 Q9Y5N1 1/20 0.40
▸ LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3598861 0.99 ALDH1A1 (0.47) ALDH1A1KDM4EPOLBHPGDAPOBEC3A
SCHEMBL3593360 0.84 NTSR1 (0.45) ALDH1A1KDM4EPOLBHPGDAPOBEC3A
SCHEMBL3601858 0.82 KDM4E (0.48) ALDH1A1KDM4EPOLBHPGDAPOBEC3A
SCHEMBL3605190 0.81 KMT2A (0.49) ALDH1A1KDM4EPOLBHPGDHSD17B10
SCHEMBL3602569 0.80 KMT2A (0.48) ALDH1A1KDM4EPOLBHPGDHSD17B10
SCHEMBL3597719 0.80 KMT2A (0.48) ALDH1A1KDM4EPOLBHPGDHSD17B10
SCHEMBL3605111 0.80 KMT2A (0.44) ALDH1A1KDM4EPOLBHPGDAPOBEC3A
SCHEMBL3593133 0.80 GRIN2B (0.43) ALDH1A1KDM4EPOLBHPGDAPOBEC3A
SCHEMBL3608528 0.77 MTNR1A (0.47) ALDH1A1KDM4EPOLBHPGDHSD17B10
SCHEMBL3595319 0.76 KDM4E (0.45) ALDH1A1KDM4EPOLBHPGDAPOBEC3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7807704-B2 Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 CHEMOCENTRYX, INC. (US) 2010-10-05 — — US disclosed
US-7807704-B2 Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 CHEMOCENTRYX, INC. (US) 2010-10-05 — — US disclosed
US-7807704-B2 Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 CHEMOCENTRYX, INC. (US) 2010-10-05 — — US disclosed
US-20070275965-A1 CXCR4 modulators CHEMOCENTRYX, INC. (US) 2007-11-29 — — US disclosed
US-20070275965-A1 CXCR4 modulators CHEMOCENTRYX, INC. (US) 2007-11-29 — — US disclosed
US-20070275965-A1 CXCR4 modulators CHEMOCENTRYX, INC. (US) 2007-11-29 — — US disclosed
WO-2007115231-A2 CXCR4 MODULATORS CHEMOCENTRYX, INC. (US) 2007-10-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275965-A1 CXCR4 modulators CXCL12, CXCR4, CXCR1 ALDH1A1 662/4885KDM4E 4801/4885POLB 4479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback